Providing market intelligence for more than 35 years

In The News

US FCC Not To Investigate Netflix Throttling Of Some Mobile Consumers

That dichotomy could also spill into an ongoing debate in Washington over how strictly to regulate the broadband companies over customer privacy. "This is outside the Open Internet", Wheeler said. Well, it looks like, if Netflix throttles you, you will have to wait until it enables the data saver mode that it promised last week, so that you can unleash the full potential of your cellular connection while streaming video. Netflix denied it made false statements, continuing to insist that what it did, it did for consumers: quote:"We have not made false statements to the FCC".

"We're at a point where there's so much video traffic going across the Internet", said Glenn Hower, a research analyst for Parks Associates.

From the article "US FCC Not To Investigate Netflix Throttling Of Some Mobile Consumers" by Noah Barnes.

Previously In The News

The future of mobile payments – are there too many options that are confusing consumers and merchants?

“Merchants are still slowly upgrading their retail point of sale (POS) systems to support various mobile payment options while new payment options keep showing up. No merchants have provided a complet...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

TV Everywhere Usage Grows

A recent article in Multichannel News provided new findings from Parks Associates showing that 40 percent of U.S. pay TV subscribers used TV Everywhere options in 2015, up from 22 percent in 2013. "TV...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...